Genetic variation in CD83 and risks of cervical and vulvar cancers: A population-based case-control study

Gynecologic Oncology

Volumn 124, Issue 3, 2012, Pages 525-528

  Bodelon, Clara ^a,b   Madeleine, Margaret M ^a,b   Johnson, Lisa G ^a   Du, Qin ^a   Malkki, Mari ^a   Petersdorf, Effie W ^a   Schwartz, Stephen M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cervix; Epidemiology; Genetics; Human papillomavirus; Vulva

Indexed keywords

CD83 ANTIGEN; VIRUS DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VULVA CARCINOMA;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84856757995     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.11.017     Document Type: Article

References (25)

1. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 2002 244 265
2. H. De Vuyst, G.M. Clifford, M.C. Nascimento, M.M. Madeleine, and S. Franceschi Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis Int J Cancer 124 2009 1626 1636
3. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
4. A.K. Chaturvedi, M.M. Madeleine, R.J. Biggar, and E.A. Engels Risk of human papillomavirus-associated cancers among persons with AIDS J Natl Cancer Inst 101 2009 1120 1130
5. A.E. Grulich, M.T. van Leeuwen, M.O. Falster, and C.M. Vajdic Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 2007 59 67
6. J. Dillner, S.K. Kjaer, and C.M. Wheeler Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial BMJ 341 2010 c3493
7. M.H. Einstein, S. Leanza, and L.G. Chiu Genetic variants in TAP are associated with high-grade cervical neoplasia Clin Cancer Res 15 2009 1019 1023
8. M.M. Madeleine, L.G. Johnson, and A.G. Smith Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk Cancer Res 68 2008 3532 3539
9. S.S. Wang, M.C. Bratti, and A.C. Rodriguez Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer J Infect Dis 199 2009 20 30
10. M. Lechmann, S. Berchtold, J. Hauber, and A. Steinkasserer CD83 on dendritic cells: more than just a marker for maturation Trends Immunol 23 2002 273 275
11. A.T. Prechtel, and A. Steinkasserer CD83: an update on functions and prospects of the maturation marker of dendritic cells Arch Dermatol Res 299 2007 59 69
12. M. Lechmann, E. Zinser, A. Golka, and A. Steinkasserer Role of CD83 in the immunomodulation of dendritic cells Int Arch Allergy Immunol 129 2002 113 118
13. S. Patel, and S. Chiplunkar Host immune responses to cervical cancer Curr Opin Obstet Gynecol 21 2009 54 59
14. I. Mellman, and R.M. Steinman Dendritic cells: specialized and regulated antigen processing machines Cell 106 2001 255 258
15. Z. Zhang, I. Borecki, and L. Nguyen CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer Cancer Res 67 2007 11202 11208
16. K.J. Yu, J.S. Rader, I. Borecki, Z. Zhang, and A. Hildesheim CD83 polymorphisms and cervical cancer risk Gynecol Oncol 114 2009 319 322
17. J.R. Daling, M.M. Madeleine, and B. McKnight The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection Cancer Epidemiol Biomarkers Prev 5 1996 541 548
18. M.M. Madeleine, J.R. Daling, and J.J. Carter Cofactors with human papillomavirus in a population-based study of vulvar cancer J Natl Cancer Inst 89 1997 1516 1523
19. B.F. Hankey, L.A. Ries, and B.K. Edwards The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiol Biomarkers Prev 8 1999 1117 1121
20. C.K. Edlund, W.H. Lee, D. Li, D.J. Van Den Berg, and D.V. Conti Snagger: a user-friendly program for incorporating additional information for tagSNP selection BMC Bioinformatics 9 2008 174
21. J.E. Wigginton, D.J. Cutler, and G.R. Abecasis A note on exact tests of Hardy-Weinberg equilibrium Am J Hum Genet 76 2005 887 893
22. J.H. Shin, S. Blay, B. McNeney, and J. Graham LDheatmap: an R function for graphical display of pairwise linkage disequilibria between single nucleotide polymorphisms J Stat Soft 16 2006
23. S. Wacholder, N. Rothman, and N. Caporaso Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias J Natl Cancer Inst 92 2000 1151 1158
24. S.F. Altekruse, J.V.J. Lacey, and L.A. Brinton Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States Am J Obstet Gynecol 188 2003 657 663
25. S. Bulk, J. Berkhof, and N.W.J. Bulkmans Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands Br J Cancer 94 2005 171 175